Clinical Trials on Glabellar Crease
Total 10000 results
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, France, Poland, Germany, Taiwan, Portugal, Netherlands, Ireland, South Korea
-
MedSIRGilead SciencesCompletedBreast Cancer | Triple Negative Breast Cancer | Advanced HR+/HER2- Breast CancerSpain
-
Fudan UniversityActive, not recruitingTNBC - Triple-Negative Breast CancerChina
-
The Methodist Hospital Research InstituteCompletedMetastatic Triple Negative Breast CancerUnited States
-
Jo ChienMerck Sharp & Dohme LLCCompletedTriple Negative Breast Cancer | Advanced or Metastatic Breast CancerUnited States
-
University of Colorado, DenverCompletedMetastatic Breast Cancer | Solid TumorsUnited States
-
Fudan UniversityCompletedAdvanced Triple-Negative Breast CancerChina
-
AHS Cancer Control AlbertaTom Baker Cancer CentreWithdrawnMetastatic Triple Negative Breast CancerCanada
-
Russian Academy of Medical SciencesCompletedEarly Triple Negative Breast CancerRussian Federation
-
Cedars-Sinai Medical CenterSummit TherapeuticsRecruitingTNBC - Triple-Negative Breast Cancer | TNBC | Early Stage Triple-Negative Breast CarcinomaUnited States
-
Rush University Medical CenterCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
-
Outcomes4MeMassachusetts General HospitalUnknownBreast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Metastatic Breast CarcinomaUnited States
-
Hutchison Medipharma LimitedCompletedRectal Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Colon Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein OverexpressionUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast CarcinomaUnited States, Puerto Rico, Mexico
-
National Cancer Institute (NCI)CompletedMale Breast Carcinoma | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage IA Breast Cancer AJCC v8 | Prognostic Stage IB Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Prognostic...United States
-
Northwestern UniversityNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage 0 Breast Cancer AJCC v8 | Prognostic Stage 0 Breast Cancer AJCC v8 | Breast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Bilateral Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedBreast Cancer | Ductal Breast Carcinoma in Situ | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in SituUnited States
-
IRCCS San RaffaeleNot yet recruiting
-
Ohio State University Comprehensive Cancer CenterLilly FoundationRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Advanced Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Avenzo Therapeutics, Inc.RecruitingHR+/HER2- Breast Cancer | HR+, HER2-, Advanced Breast CancerUnited States
-
Yale UniversityAstellas Pharma US, Inc.RecruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)United States
-
Parc de Salut MarEuropean Regional Development Fund; Biomedical Research Networking Center on... and other collaboratorsNot yet recruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)Spain
-
British Columbia Cancer AgencyNot yet recruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)
-
Guangzhou Women and Children's Medical CenterNot yet recruitingHER2 Low Breast Cancer | Breast Cancer, Estrogen Receptor-Positive
-
European Institute of OncologyRecruitingBreast Cancer Early Stage Breast Cancer (Stage 1-3)Italy
-
Fudan UniversityNot yet recruitingNeoadjuvant Therapy | Early Breast Cancer | HR+HER2- Breast Cancer
-
University of MiamiRecruitingStage IV Breast Cancer | HER2-positive Metastatic Breast CancerUnited States
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerGermany
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerJapan, United States, Germany, Spain, Taiwan, Belgium, Poland, Thailand, Brazil, Canada, United Kingdom, India, China, Hungary, Israel, Austria, Bulgaria, South Africa, France, Australia, Mexico, Argentina, Greece, Malaysia, Peru, Philipp... and more
-
Centre Francois BaclesseRecruiting
-
Meir Medical CenterTel Aviv UniversityNot yet recruitingMalignant Tumor of Breast | Benign Breast Lumps | High-Risk Breast Cancer
-
University of Wisconsin, MadisonRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Olema Pharmaceuticals, Inc.CompletedHormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States, Australia
-
Parc de Salut MarEnrolling by invitationBreast Cancer Early Stage Breast Cancer (Stage 1-3)Spain
-
Inova Health Care ServicesCity of Hope Medical CenterTerminatedBreast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompletedEndoscopic Breast Surgery | Benign Breast TumorsChina
-
Kari WisinskiPfizer; Celcuity IncActive, not recruitingTNBC - Triple-Negative Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer (MBC) | Inoperable Locally Advanced Breast CancerFrance, Spain
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
University College, LondonUnknownRadiotherapy | Breast Conserving Surgery | Women With Early Breast CancerUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterCompletedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Ahmet YesildagRecruitingBreast Neoplasm Female | Benign Breast Neoplasm | Malign Breast Neoplasm | Doppler Ultrasound DiagnosisTurkey (Türkiye)
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingEstrogen Receptor Positive | Ductal Breast Carcinoma In Situ | Grade 1 Invasive Breast Carcinoma | Grade 2 Invasive Breast Carcinoma | Grade 3 Invasive Breast Carcinoma | Invasive Ductal and Lobular Carcinoma In Situ | Mucinous Breast Carcinoma | Tubular Breast CarcinomaUnited States
-
Telomir Pharmaceuticals, Inc.Not yet recruitingTriple-Negative Breast Cancer (TNBC) | Metastatic Triple-negative Breast Cancer | Advanced Triple-Negative Breast Cancer
-
Gangnam Severance HospitalSeoul National UniversityRecruitingBreast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive Tumor | Premenopausal Breast Cancer | Node-positive Breast CancerKorea, Republic of